267 related articles for article (PubMed ID: 7685244)
1. CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells.
Katsuno M; Abe Y; Taguchi F; Yufu Y; Sadamura S; Goto T; Takatsuki H; Nishimura J; Hirata J; Akiyoshi T
Cancer; 1993 Jul; 72(1):99-104. PubMed ID: 7685244
[TBL] [Abstract][Full Text] [Related]
2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
3. T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination.
Nagano M; Kimura N; Akiyoshi T; Nishimura J; Kozuru M; Okamura J; Katsuno M; Yoshida T; Takeshita M; Tachibana K; Ohshima K; Kikuchi M
Leuk Res; 1997 Aug; 21(8):763-73. PubMed ID: 9379684
[TBL] [Abstract][Full Text] [Related]
4. [CD7 (+) stem cell leukemia presenting different phenotypes in lymph node and bone marrow].
Goda H; Abe Y; Yufu Y; Muta K; Katsuno M; Goto T; Sadamura S; Nishimura J; Nawata H; Hirata J
Rinsho Ketsueki; 1992 Aug; 33(8):1046-51. PubMed ID: 1383580
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
7. CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia.
Tasaka T; Nagai M; Murao S; Yamaguchi M; Kitanaka A; Sasaki K; Murata M; Tanaka T; Kuwabara H; Ikeda K
Am J Hematol; 1993 Sep; 44(1):53-7. PubMed ID: 7688180
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
9. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
10. [CD7 positive undifferenciated leukemia/lymphoma associated with leukemic pericarditis].
Ochi K; Amano M; Soda Y; Togawa A; Takaku F
Rinsho Ketsueki; 1994 Jul; 35(7):665-9. PubMed ID: 7520512
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia.
Yumura-Yagi K; Hara J; Kurahashi H; Okamura J; Koizumi S; Toyoda Y; Murayama N; Inoue M; Ishihara S; Tawa A
Cancer; 1991 Nov; 68(10):2273-80. PubMed ID: 1717122
[TBL] [Abstract][Full Text] [Related]
12. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
Smith MR; Mohamed AN; Karanes C
Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
[TBL] [Abstract][Full Text] [Related]
13. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
[TBL] [Abstract][Full Text] [Related]
14. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of immunological dissection in T-ALL: a report on 20 cases with stem cell (CD7+, CD4-, CD8-, CD1-) phenotype.
Ferrara F; Cimino R; Antinolfi I; De Rosa C; Mele G; Mettivier V; Fusco C; Del Vecchio L
Am J Hematol; 1992 Jun; 40(2):98-102. PubMed ID: 1375001
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
Kita K; Miwa H; Nakase K; Kawakami K; Kobayashi T; Shirakawa S; Tanaka I; Ohta C; Tsutani H; Oguma S
Blood; 1993 May; 81(9):2399-405. PubMed ID: 7683218
[TBL] [Abstract][Full Text] [Related]
19. T-cell receptor gamma/delta expressing acute leukemia emerging from sideroblastic anemia: morphological, immunological, and cytogenetic features.
Meckenstock G; Fonatsch C; Heyll A; Schneider EM; Kögler G; Söhngen D; Aul C; Schneider W
Leuk Res; 1992; 16(4):379-84. PubMed ID: 1373459
[TBL] [Abstract][Full Text] [Related]
20. Genuine CD7 expression in acute leukemia and lymphoblastic lymphoma.
Osada H; Emi N; Ueda R; Seto M; Koike K; Suchi T; Kojima S; Obata Y; Takahashi T
Leuk Res; 1990; 14(10):869-77. PubMed ID: 1701841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
